Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis
Objectives To review clinical validation or implementation studies of maternal blood cell‐free
(cf) DNA analysis and define the performance of screening for fetal trisomies 21, 18 and 13 …
(cf) DNA analysis and define the performance of screening for fetal trisomies 21, 18 and 13 …
Sequencing of circulating cell-free DNA during pregnancy
Sequencing of Circulating Cell-free DNA during Pregnancy | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Skip to main content The New England Journal of Medicine homepage Advanced Search …
[HTML][HTML] Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics
AR Gregg, BG Skotko, JL Benkendorf, KG Monaghan… - Genetics in …, 2016 - Elsevier
Disclaimer: This statement is designed primarily as an educational resource for clinicians to
help them provide quality medical services. Adherence to this statement is completely …
help them provide quality medical services. Adherence to this statement is completely …
Where do batteries end and supercapacitors begin?
Batteries keep our devices working throughout the day–that is, they have a high energy
density–but they can take hours to recharge when they run down. For rapid power delivery …
density–but they can take hours to recharge when they run down. For rapid power delivery …
Identification of tissue-specific cell death using methylation patterns of circulating DNA
R Lehmann-Werman, D Neiman… - Proceedings of the …, 2016 - National Acad Sciences
Minimally invasive detection of cell death could prove an invaluable resource in many
physiologic and pathologic situations. Cell-free circulating DNA (cfDNA) released from dying …
physiologic and pathologic situations. Cell-free circulating DNA (cfDNA) released from dying …
Plasma DNA tissue map** by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
Plasma consists of DNA released from multiple tissues within the body. Using genome-wide
bisulfite sequencing of plasma DNA and deconvolution of the sequencing data with …
bisulfite sequencing of plasma DNA and deconvolution of the sequencing data with …
Cell-free DNA analysis for noninvasive examination of trisomy
Background Cell-free DNA (cfDNA) testing for fetal trisomy is highly effective among high-
risk women. However, there have been few direct, well-powered studies comparing cfDNA …
risk women. However, there have been few direct, well-powered studies comparing cfDNA …
Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis
MM Gil, MS Quezada, R Revello… - … in obstetrics & …, 2015 - Wiley Online Library
Objective To review clinical validation or implementation studies of maternal blood cell‐free
(cf) DNA analysis and define the performance of screening for fetal trisomies 21, 18 and 13 …
(cf) DNA analysis and define the performance of screening for fetal trisomies 21, 18 and 13 …
Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies
Precision oncology is predicated upon the ability to detect specific actionable genomic
alterations and to monitor their adaptive evolution during treatment to counter resistance …
alterations and to monitor their adaptive evolution during treatment to counter resistance …
Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis
S Taylor-Phillips, K Freeman, J Geppert, A Agbebiyi… - BMJ open, 2016 - bmjopen.bmj.com
Objective To measure test accuracy of non-invasive prenatal testing (NIPT) for Down,
Edwards and Patau syndromes using cell-free fetal DNA and identify factors affecting …
Edwards and Patau syndromes using cell-free fetal DNA and identify factors affecting …